However, these methods have inherent limitations: biopsies are invasive and unsuitable for repeated monitoring, tumor heterogeneity can lead to inaccurate results, and neither biopsy nor IHC provides real-time, whole-body EGFR expression data [8]. Here, EGFR is linked to neoplasm.